aTyr Pharma reported 765K in Interest Expense on Debt for its fiscal quarter ending in December of 2025.





Interest Expense On Debt Change Date
Ardelyx USD 5.76M 37K Dec/2025
Biogen USD 72.6M 12.6M Jun/2025
Bristol-Myers Squibb USD 432M 48M Dec/2025
Cipla INR 140.3M 8.5M Dec/2025
Compugen USD 954K 116K Sep/2025
CSL USD 215M 111M Dec/2025
Curis USD 178K 441K Dec/2023
Galapagos EUR 1.72M 940K Sep/2025
GlaxoSmithKline GBP 188M 21M Dec/2025
Grifols EUR 156.07M 31.46M Sep/2025
Novartis USD 304M 23M Dec/2025
Roche Holding CHF 304M 7.5M Jun/2025
United Therapeutics USD 3.1M 100K Dec/2025
Xoma USD 3.4M 150K Jun/2024